Euro'vision
The (r)evolution of the digital agency
It seems every ‘traditional’ agency has had to have one – if only by association or acquisition. But rather than the ‘interactive agency’ ruling the world, Max Jackson sees something of a sea change…
...01 May 2012
Open dialogue and the industry – an unpalatable reality
With the closing of Janssen’s Psoriasis 360 Facebook page – Max explains why he believes that the social interaction websites are unsuited to prescription-only products. Add your comment, to say what you think.
...02 Apr 2012
Online disease management – white knight or white elephant?
Online disease management and compliance tools are proliferating at a steady rate on the web. Everyone is investing heavily – but where is it all getting us, or indeed the online users?
...28 Feb 2012
Data goes into overdrive
Suddenly – data might be getting a whole lot more complicated… Access to your data is big business – enough to have driven up the value of Facebook phenomenally. A recently published EU proposal may set out to protect your privacy, ...
01 Feb 2012
Life’s a Pitch!!
Our Spanish agency made 70 face-to-face pitches last year. So, are economical constraints pushing pharma marketers and their procurement colleagues to adopt an approach to tendering work that’s counterproductive?
...19 Jan 2012
Food for thought
By now most of us have eaten our last plate of cold turkey, recycled the Christmas tree, and exchanged the five identical sweaters given us by loving friends and family. So it’s timely, I felt, to come up ...
04 Jan 2012
Following Yonder Star…
The legends tell us that this is the time of year when Wise Men look for meanings in the heavens, and long foretold prophesies come to life. So it’s a fitting season to once again look at the long ...
14 Dec 2011
Standing on the shoulders of giants
Has a world where we are ring fenced by financial and legal scrutiny brought us to a safe area where over-cautiousness prevails? Max Jackson reflects on those who contribute a colourful sense of ingenuity and bravado… ...
29 Nov 2011
AMNOG – trick or treat?
It’s referred to as the “reorganisation of the pharma market”. What exactly are the implications of the German AMNOG legislation, adopted by Bundestag (the national parliament), and will other countries follow suit? ...
10 Nov 2011
Is there a doctor in the house?
We hear much talk about the future of pharma being focused on producing more innovative medicines and reaching new markets. But the key players in the industry within Europe have something else on their minds…
...
27 Oct 2011